glp-1 criteria for use Nearly Four Million Medicare Beneficiaries Met the Eligibility in 2023 the Medicare Bridge Liraglutide: for obesity, not just

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease

Important new real-world data published in Annals of Internal Medicine suggests an increased risk of gastroesophageal reflux disease (GERD) in patients with type 2 diabetes (T2D) using GLP-1s

doi: 10.1016/j.ejca.2013.09.007 173 ShoushtariANWagstaffJAsciertoPAButlerMOLaoCDMarquez-RodasIet al

An increase in BMI and abdominal obesity in postmenopausal women show about 5 times higher risk of central obesity compared to premenopausal women [44]

5 Functional Fixes to Strengthen Gut and Brain Health Lets talk about what you can control even before diving into advanced therapies

This work was partially supported by National Natural Science Foundation of China 81872915 (MW), 82073904 (MW), 82121005 (DY), 81973373 (DY) and 21704064 (QZ)